Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection.

Rathbun RC, Lockhart SM, Miller MM, Liedtke MD. Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection. Ann Pharmacother. 2014 Mar; 48(3):395-403.

View in: PubMed

subject areas

Alkynes
Alkynes
Benzoxazines
Benzoxazines
Clinical Trials as Topic
Clinical Trials as Topic
Cyclopropanes
Cyclopropanes
Drug Combinations
Drug Combinations
Drug Interactions
Drug Interactions
Half-Life
Half-Life
Heterocyclic Compounds, 3-Ring
Heterocyclic Compounds, 3-Ring
HIV Infections
HIV Infections
HIV Integrase Inhibitors
HIV Integrase Inhibitors
HIV Protease Inhibitors
HIV Protease Inhibitors
Humans
Humans
Oxazines
Oxazines
Piperazines
Piperazines
Pyridones
Pyridones
Pyrrolidinones
Pyrrolidinones
Raltegravir Potassium
Raltegravir Potassium
Reverse Transcriptase Inhibitors
Reverse Transcriptase Inhibitors
Ritonavir
Ritonavir

authors with profiles

Robert C Rathbun
Misty Marie Miller